Congress joins fight over rising cost of EpiPens as Shkreli defends By: MarketWatch August 24, 2016 at 11:42 AM EDT Congress is asking for investigations and answers on Mylan’s increase of EpiPen pricing, while the company blames it on Obamacare. Read More >> Related Stocks: Mylan Standard & Poors 500